Average Co-Inventor Count = 4.67
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Defensin Therapeutics Aps (4 from 4 patents)
2. Novozymes Adenium Biotech A/s (2 from 8 patents)
3. Adenium Biotech Aps (1 from 1 patent)
7 patents:
1. 9833495 - Oral treatment of inflammatory bowel disease
2. 9279010 - Treatment of inflammatory bowel diseases with mammal beta defensins
3. 9217021 - Oral treatment of inflammatory bowel disease
4. 8802621 - Treatment of inflammatory bowel diseases with mammal beta defensins
5. 8653024 - Use of AMPs for treatment of UTI/cystitis
6. 8232242 - Treatment of inflammatory bowel diseases with mammal beta defensins
7. 8232248 - Treatment of rheumatoid arthritis with mammal beta defensins